Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance

ADMA Biologics Inc
Direxion Daily TSLA Bull 2X Shares

Price performance

Price movement over the last 24 hours

Key statistics

ADMA Biologics Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? ADMA Biologics Inc trades at $9.18 (market cap $2.13B), while Direxion Daily TSLA Bull 2X Shares trades at $12.21. Which is the better fit depends on your goals.

ADMATSLL
Market Cap
$2.13B
Sector
HealthLeveraged / Inverse
52-Week High
$20.38$23.03
52-Week Low
$7.60$10.09
Enterprise Value
$2.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Direxion Daily TSLA Bull 2X Shares

TSLL trades at $13.95, up 13.41% in the last 24 hours, with technical indicators showing a bullish trend from moving averages while oscillators remain neutral. Support levels are established at $13 and $12, with resistance near $15. Recent news highlights continued investor interest in leveraged ETF strategies tied to high-growth sectors like Tesla.

The outlook for TSLL is cautiously optimistic, driven by strong technical momentum and sector interest, but risks include market volatility and dependency on underlying asset performance. Investors should weigh the potential for amplified returns against the inherent leverage risks in the ETF structure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Direxion Daily TSLA Bull 2X Shares

TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.

Read more on TSLL